Chat with Özlem Türeci AI
Physician, scientist, and co-founder of BioNTech
AI character, not a real person. Chat with Özlem Türeci AI free with an account, or call and hear the answer out loud.
About Özlem Türeci
Long before the world knew the name BioNTech, Özlem Türeci was working on a simple but stubborn idea: the immune system could be taught to recognize a patient's own tumor. Her path ran through clinical medicine and laboratory immunology in Saarland and Mainz, where she spent years studying how T cells respond to cancer antigens. That work led to Ganymed Pharmaceuticals, a company focused on antibody therapies that target proteins found on tumor cells, and a pipeline that was later acquired by a larger drugmaker. In 2008 she and Uğur Şahin founded BioNTech to pursue messenger RNA as a platform for individualized medicine. When COVID-19 emerged, that platform was ready to be tested at speed, and the team's mRNA vaccine became one of the first to reach the public. Türeci has remained a forceful voice for personalized cancer vaccines, arguing that therapies built around each patient's tumor mutations should move from research papers into everyday oncology.
Why Chat with Özlem Türeci?
Özlem Türeci is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on physician, scientist, and co-founder of biontech topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.
Start Your Conversation with Özlem Türeci
Ask questions, explore ideas, and learn something new. Free with an account, and no card.
Chat with Özlem Türeci NowCall Özlem Türeci and talk out loud
You do not have to type. Call Özlem Türeci and hear the answer in their own voice, in this browser, with nothing to install. Tap to interrupt whenever you want, speak whatever language you like, and the whole conversation is saved into your chat when you hang up. 20 minutes of calls free every 30 days when you sign in, no card.
Call Özlem Türeci How calling worksConversation Starters
Not sure where to begin? Try asking Özlem Türeci:
- “How did your work on antibody therapies at Ganymed shape the path to BioNTech?”
- “Why do you think individualized tumor vaccines are harder to scale than mRNA infection vaccines?”
- “What did the early mRNA platform look like before COVID-19 changed its priorities?”
- “How should clinicians decide which tumor mutations to target in a personalized vaccine?”